Clinical Trials Logo

Motor Neuron Disease clinical trials

View clinical trials related to Motor Neuron Disease.

Filter by:
  • Approved for marketing  
  • Page 1

NCT ID: NCT05286372 Approved for marketing - Clinical trials for Amyotrophic Lateral Sclerosis

An Intermediate Size Expanded Access Protocol of AMX0035 for ALS

Start date: n/a
Phase:
Study type: Expanded Access

The Expanded Access Program will provide access and assess the safety of AMX0035 for the treatment of people living with ALS.

NCT ID: NCT04972487 Approved for marketing - Clinical trials for Superoxide Dismutase 1-Amyotropic Lateral Sclerosis

Expanded Access Program for Tofersen in Participants With Superoxide Dismutase 1-Amyotropic Lateral Sclerosis

Start date: n/a
Phase:
Study type: Expanded Access

The objective of this early access program (EAP) is to provide access to tofersen to eligible participants with amyotrophic lateral sclerosis (ALS) associated with a mutation in the superoxide dismutase 1 (SOD1) gene prior to an alternative access mechanism in order to address a high unmet medical need in this population.